BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

(2015) Emma Börgeson et al.   Cell Metabolism

Protective Effects of BML-111 on Cerulein-Induced Acute Pancreatitis-Associated Lung Injury via Activation of Nrf2/ARE Signaling Pathway

(2014) Ying-zhen Wang et al.   INFLAMMATION

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4receptor agonist, BML-111, in a rat model of ischemic stroke

(2013) Kimberly E. Hawkins et al.   JOURNAL OF NEUROCHEMISTRY

Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGF R1

(2013) E. P. Brennan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Involvement of K+ channel-dependant pathways in lipoxin A4-induced protective effects on hypoxia/reoxygenation injury of cardiomyocytes

(2013) Xiao-Qing Chen et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats

(2012) Jie Gong et al.   RESUSCITATION

Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis

(2011) Emma Börgeson et al.   FASEB JOURNAL

Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-Heme oxygenase-1 signaling pathway

(2011) Ching-Feng Cheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

HO-1 Induced by Cilostazol Protects Against TNF-α-associated Cytotoxicity via a PPAR-γ-dependent Pathway in Human Endothelial Cells

(2011) So Youn Park et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Ischemia and reperfusion—from mechanism to translation

(2011) Holger K Eltzschig et al.   NATURE MEDICINE

Lipoxin A4 Inhibits Transition of Epithelial to Mesenchymal Cells in Proximal Tubules

(2010) Sheng-Hua Wu et al.   AMERICAN JOURNAL OF NEPHROLOGY

Adiponectin-Mediated Heme Oxygenase-1 Induction Protects Against Iron-Induced Liver Injury via a PPARα-Dependent Mechanism

(2010) Heng Lin et al.   AMERICAN JOURNAL OF PATHOLOGY

The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury

(2010) Gianluca Miglio et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pravastatin Attenuates Carboplatin-Induced Nephrotoxicity in Rodents via Peroxisome Proliferator-Activated Receptor  -Regulated Heme Oxygenase-1

(2010) H.-H. Chen et al.   MOLECULAR PHARMACOLOGY

Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPAR -Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke

(2009) M. Sobrado et al.   JOURNAL OF NEUROSCIENCE

Transgenic expression of proximal tubule peroxisome proliferator–activated receptor-α in mice confers protection during acute kidney injury

(2009) Shenyang Li et al.   KIDNEY INTERNATIONAL

Signal pathway involved in inhibition by lipoxin A4 of production of interleukins induced in endothelial cells by lipopolysaccharide

(2008) Sheng-Hua Wu et al.   INFLAMMATION RESEARCH

BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis

(2008) L. Zhang et al.   INFLAMMATION RESEARCH

Peroxisome Proliferator-Activated Receptor-  Contributes to the Resolution of Inflammation after Renal Ischemia/Reperfusion Injury

(2008) N. S. A. Patel et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Mechanisms Mediating Reduced Responsiveness of Neonatal Neutrophils to Lipoxin A4

(2008) Barry Weinberger et al.   PEDIATRIC RESEARCH

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

(2007) C N Serhan et al.   BRITISH JOURNAL OF PHARMACOLOGY